Publications by authors named "Tetsuo Mashima"

Claim this Profile
I
Intratumor transforming growth factor-β signaling with extracellular matrix-related gene regulation marks chemotherapy-resistant gastric cancer.
Ayane Nakamura, Tetsuo Mashima, Jin Lee, Saori Inaba, Naomi Kawata

Biochem Biophys Res Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia.
Ryo Yanagiya, Yuji Miyatake, Natsumi Watanabe, Takanobu Shimizu, Akane Kanamori, Tetsuo Mashima

Leukemia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer.
Mitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, Shingo Dan, Hiroyuki Seimiya

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer.
Jin Lee, Tetsuo Mashima, Naomi Kawata, Noriko Yamamoto, Shun Morino

Cancer Res Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET protein-dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer.
Shun Morino, Tetsuo Mashima, Fumiyuki Shirai, Satoshi Nagayama, Ryohei Katayama

Cancer Lett· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8 T cell infiltration in melanoma.
Shiho Hirose, Tetsuo Mashima, Xunmei Yuan, Makiko Yamashita, Shigehisa Kitano

Cancer Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
Mingjue Chen, Tetsuo Mashima, Taichi Oishi, Yukiko Muramatsu, Yosuke Seto

Br J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients.
Mitsukuni Suenaga, W U Zhang, Tetsuo Mashima, Marta Schirripa, Shu Cao

Cancer Genomics Proteomics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo.
Tetsuo Mashima, Takeru Wakatsuki, Naomi Kawata, Myung-Kyu Jang, Akiko Nagamori

Sci Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
Naoyuki Nishiya, Yusuke Oku, Chie Ishikawa, Tsutomu Fukuda, Shingo Dan, Tetsuo Mashima

Cancer Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum IL-8 level as a candidate prognostic marker of response to anti-angiogenic therapy for metastatic colorectal cancer.
Mitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, Takeru Wakatsuki, Shingo Dan

Int J Colorectal Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cells.
Fumiya Tomizawa, Myung-Kyu Jang, Tetsuo Mashima, Hiroyuki Seimiya

Biochem Biophys Res Commun· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase.
Myung-Kyu Jang, Tetsuo Mashima, Hiroyuki Seimiya

Mol Cancer Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.
Ryuhei Kawakami, Tetsuo Mashima, Naomi Kawata, Koshi Kumagai, Toshiro Migita

Cancer Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.
Mitsukuni Suenaga, Takeru Wakatsuki, Tetsuo Mashima, Mariko Ogura, Takashi Ichimura

Invest New Drugs· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib.
Satoshi Matsusaka, Diana L Hanna, Yan Ning, Dongyun Yang, Shu Cao, Tetsuo Mashima

Cancer Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.
Tetsuo Mashima, Risa Iwasaki, Naomi Kawata, Ryuhei Kawakami, Koshi Kumagai

Br J Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report of the 14th Japan-Korea joint symposium on cancer and aging research: current status of translational research and approaches to precision medicine.
Eisaburo Sueoka, Tatsuro Watanabe, Tetsuo Mashima, Yohei Shirakami, Atsumasa Komori

J Cancer Res Clin Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.
Hiroki Osumi, Eiji Shinozaki, Tetsuo Mashima, Takeru Wakatsuki, Mitsukuni Suenaga

Cancer Sci· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, Wu Zhang, Dongyun Yang, Tetsuo Mashima

Clin Colorectal Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
Tetsuo Mashima, Yoko Taneda, Myung-Kyu Jang, Anna Mizutani, Yukiko Muramatsu

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmaceutical Sciences Advancing Molecular Cancer Therapeutics～To Improve Rationale and Effectiveness of Molecularly Targeted Drugs～].
Kohji Noguchi, Tetsuo Mashima

Yakugaku Zasshi· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
Tetsuo Mashima

Yakugaku Zasshi· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer.
Noritaka Tanaka, Tetsuo Mashima, Anna Mizutani, Ayana Sato, Aki Aoyama

Mol Cancer Ther· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer.
Mitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, Takeru Wakatsuki, Yuki Horiike

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis